COLLEGE OF AGRICULTURE
Allylix Inc.
Carolyn Fritz, cfritz@allylix.com, 859.243.5777 (lab), 859.510.332.9142 (cell)
www.allylix.com
Allylix is combining leading edge research in molecular genetics, biochemistry and structural biology from the University of Kentucky and The Salk Institute for Biological Studies to produce natural products called terpenes for the flavor & fragrance and insect repellent markets. Using its extensive intellectual property, Allylix can create diverse collections of fine chemicals, especially chiral chemicals, rapidly generating molecules that possess the properties of natural products, as well as scale up production of high-value single entity compounds.
Naprogenix Inc.
122 Kentucky Tobacco Research & Development Center, University of Kentucky, Lexington, KY 40546-0236
Cindy A. Burklow, cindy_burklow@yahoo.com, 859/257-1127
www.naprogenix.com
Naprogenix is commercializing its bioprospecting technology targeting the pharmaceutical, nutraceutical, and agrochemical industries. Our proprietary Biotech & Healthcare is aimed at discovering novel plant-based natural products through Natural Products Genomics™ (NPG). NPG is a functional genomics platform technology that combines a novel mutagenic strategy with a uniquely efficient cell culture screening process. Its objective is to identify and express the gene sequences that are responsible for the production of naturally occurring, secondary, small molecule metabolites, or botanical compounds, with desired biological activity. The result will be the formation of intellectual property through the identification of novel therapeutic compounds, the genetic sequences responsible for their production, and a new genetically modified plant species which are all patentable. Based on the research of John Littleton (molecular and biomedical pharmacology).
ParaTechs
A205 ASTeCC Building, University of Kentucky, Lexington, KY 40506-0286
Angelika Fath-Goodin, agoodin@paratechs.com, 859/433-5293
www.paratechs.com
Paratechs applies advances in insect molecular biology to develop insect control and natural product technologies. Paratech’s technologies address market-proven needs with significant advantages over existing technologies. Two proprietary technologies are under development. The first provides an alternative to conventional methods of agricultural pest control by utilizing proteins from insect pathogens to inhibit the growth and development of insect pests. The second uses genes derived from insect viruses to enhance protein expression and reduces input costs in biomanufacturing. Paratech's technologies are based on the research of UK entomologist Bruce Webb.
PhylloTech
George Wagner, gwagner@uky.edu, 859/257-5974
Phyllotech has discovered a novel natural fungicide that may provide a treatment for a major class of fungal pathogens. Currently, golf courses, vegetable producers, and farmers spend more than $300 million per year on treatments for controlling these fungal pathogens, and are eager for safe, economical, and effective alternatives to currently used, environmentally unfriendly treatments. Phyllotech seeks to develop a solution to these fungal diseases and explore other applications of their technology. The company’s proprietary technology is based on research conducted at the University of Kentucky by George Wagner, an expert in plant leaf surface biology, and Ryan Shepher, currently at the University of California, Berkeley.
TranSecurity Systems
Fred Payne, fpayne1@uky.edu, 859/257-3000 ext. 220